Current Neuro-Oncology

Volume 28 Number 18
30 June 2026

Home > Publications > Current Neuro-Oncology > Volume 28, Year 2026 > Number 18, 30 June

Hong B, Chaib H, Moros G, Tsoy Y, Ziegler S, Heissler HE, Mawrin C, Shiban E.
Impact of weak MGMT promoter methylation on the prognosis of patients with newly diagnosed glioblastoma.
J Neurosurg Sci. 2026 Jun 23. doi: 10.23736/S0390-5616.26.06772-X. PMID: 42334248˰ ˍ

Wu B, Zhang Z, Ma H, Huang J, Liu X, Shi L, Dong X, Lei D, Wang X, Zhang F, Zhao H, Lin H, Fu R, Zou Z, Qin Y, Wang H, Hu X, Yao D, Yang L, Yang J, Hong X, Wang J, Wen L, Zhang C, Liang Z, Yang Z, Nie X, Liu G, Hu F, Peng G, Jiang X, Yang K.
Postoperative anlotinib plus radiotherapy in patients with newly diagnosed, unmethylated O⁶-methylguanine-DNA methyltransferase glioblastoma: A single-arm, phase 2 study.
Cancer. 2026 Jun 24;132(13):e70502. doi: 10.1002/cncr.70502. PMID: 42339996. Trial registration ID: ChiCTR2000040116. ˍ

Anghileri E, Marcassoli A, Villani V, Didato G, Milanaccio C, Pasini E, Bennicelli E, Persico P, Bini P, Berzero G, Mastronuzzi A, Filippi M, De Palma L, Arcara G, Bellini A, Maschio M, Pace A, Farinotti M, Silvani A; National Virtual Institute of Italian Network of Neuroscience.
Mapping integrated care for brain tumour-related epilepsy in the Italian RIN-IRCCS network.
Neurol Sci. 2026 Jun 26;47(7):589. doi: 10.1007/s10072-026-09188-w. PMID: 42350833. ˍ

Lindsay HB, Billups CA, Kocak M, Alban TJ, Young Poussaint T, Wong P, Chan TA, Kovacic B, Makarov V, Juric I, Diaz-Montero CM, Srivastava R, Pavicic P, Parthasarathy P, Lenzen A, MacDonald TJ, Pollack IF, Vinitsky A, Robison NJ, Baxter P, Hwang EI, Leggas M, Khalil DN, Fangusaro J, Onar-Thomas A, Dunkel IJ.
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.
Clin Cancer Res. 2026 Jun 30. doi: 10.1158/1078-0432.CCR-26-0655. PMID: 42377093. Trial registration ID: NCT03389802˰ ˍ

Zhang L, Wang H, Huang G, Qi X, Carcaboso AM, Wang C, Feng J, Han S, Cheng Z, Ma Z, Yang Y, Xu H, Chen M, Li Y, Zhang X, Cui G, Lyu J, Duan Z, Xu A, Yan C.
The clinical and molecular landscape of thalamic glioma.
Neuro Oncol. 2026 Jun 30:noag146. doi: 10.1093/neuonc/noag146. PMID: 42377275. ˍ

Arumugam A, Meira Castro Trindade R, Hendricks A, Powell MR, Bansal J.
Brain Metastasis Occurring a Decade After Prostate Cancer Diagnosis: A Case Report.
Cureus. 2026 May 27;18(5):e109715. doi: 10.7759/cureus.109715. PMID: 42367519. ˍ

Connelly JM, Zoss CJ, Szabo A, Mirza SP, Adom F, Bernstein LR, Al-Gizawiy MM, Schmainda KM, Chitambar CR.
A phase 1 trial of iron metabolism-targeting oral gallium maltolate in recurrent and refractory glioblastoma.
Neurooncol Adv. 2026 Jun 8;8(1):vdag154. doi: 10.1093/noajnl/vdag154. PMID: 42333305. Trial registration ID: NCT04319276. ˍ

Lucas A, Peereboom D, Rauf Y, Li H, Hanlon J, Ahluwalia M.
Phase 2 study of regorafenib in patients with progressive glioblastoma after failure of bevacizumab.
Neurooncol Adv. 2026 Jun 9;8(1):vdag144. doi: 10.1093/noajnl/vdag144. PMID: 42325608. Trial registration ID: NCT04051606. ˍ

Anvari K, Javadinia SA, Fazilatpanah D, Esmaily H, Aledavood SA, Shahidsales S, Ganjeifar B, Dayani M, Rabiei P.
Comparing the Recurrence Patterns of Reduced-Margins vs. RTOG-Protocol in Adjuvant Chemoradiation of High-Grade Gliomas: A Multicenter, Open-Label, Randomized Controlled Trial.
Asian Pac J Cancer Prev. 2026 Jun 18;27(6):2005-2013. doi: 10.31557/APJCP.2026.27.6.2005. PMID: 42345146. Trial registration ID: IRCT20210215050367N1. ˍ

*Giordano FA, Ganslandt O, Münter MW, Combs SE, Diehl C, Meyer B, Herrlinger U, Schneider M, Kahl KH, Shiban E, Goenka A, Schulder M, Lucas A, Plans G, Brehmer S, Ruder AM, García-Cabezas S, Solivera J, Cifarelli CP, Wenz F, Sarria GR, Pope WB, Layer JP, Tsien CI, Petrecca K; INTRAGO-II Study Group.
Dose escalation with intraoperative radiotherapy in newly diagnosed glioblastoma (INTRAGO-II): an open-label, multicentre, randomised, controlled, phase 3 trial.
Lancet Oncol. 2026 Jun 29;27(7):864-878. doi: 10.1016/S1470-2045(26)00235-4. PMID: 42372746. Trial registration ID: NCT02685605. ˍ